• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes.

作者信息

Kotecha Rupesh, Mehta Minesh P

机构信息

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.

Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.

出版信息

Neuro Oncol. 2020 Aug 17;22(8):1062-1064. doi: 10.1093/neuonc/noaa133.

DOI:10.1093/neuonc/noaa133
PMID:32479631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7594564/
Abstract
摘要

相似文献

1
Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes.新诊断胶质母细胞瘤的超分割放疗：原理、剂量、技术及结果
Neuro Oncol. 2020 Aug 17;22(8):1062-1064. doi: 10.1093/neuonc/noaa133.
2
Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.立体定向放射外科和低分割放射治疗胶质母细胞瘤。
Neurosurgery. 2018 Jan 1;82(1):24-34. doi: 10.1093/neuros/nyx115.
3
Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.低分割治疗胶质母细胞瘤的生存情况：系统评价和荟萃分析。
Radiat Oncol. 2020 Jun 8;15(1):145. doi: 10.1186/s13014-020-01584-6.
4
New Hypofractionation Radiation Strategies for Glioblastoma.胶质母细胞瘤的新超分割放疗策略
Curr Oncol Rep. 2017 Sep;19(9):58. doi: 10.1007/s11912-017-0616-3.
5
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes.一项新诊断的胶质母细胞瘤患者采用 5 毫米边缘 5 分数次立体定向放射外科手术联合替莫唑胺治疗的 I/II 期临床试验：主要结果。
Neuro Oncol. 2020 Aug 17;22(8):1182-1189. doi: 10.1093/neuonc/noaa019.
6
Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).新诊断的胶质母细胞瘤中同步和辅助替莫唑胺的低分割加速放疗（HART）：一项 II 期随机试验（HART-GBM 试验）。
J Neurooncol. 2018 Oct;140(1):75-82. doi: 10.1007/s11060-018-2932-3. Epub 2018 Jun 23.
7
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.对于年龄≥75 岁的老年胶质母细胞瘤患者，低分割放疗联合替莫唑胺或替莫唑胺联合贝伐珠单抗治疗的生存获益。
Radiat Oncol. 2019 Nov 12;14(1):200. doi: 10.1186/s13014-019-1389-7.
8
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis.老年新诊断预后不良胶质母细胞瘤患者短程分割放射治疗的II期研究
Tumori. 2019 Feb;105(1):47-54. doi: 10.1177/0300891618792483. Epub 2018 Aug 22.
9
Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.低分割放射治疗联合替莫唑胺治疗伴预后不良因素的胶质母细胞瘤患者：单中心前瞻性经验。
PLoS One. 2019 Jun 6;14(6):e0217881. doi: 10.1371/journal.pone.0217881. eCollection 2019.
10
The radiosurgery fractionation quandary: single fraction or hypofractionation?放射外科的分次治疗难题：单次分割还是低分割？
Neuro Oncol. 2017 Apr 1;19(suppl_2):ii38-ii49. doi: 10.1093/neuonc/now301.

引用本文的文献

1
Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution.程序性细胞死亡破坏炎症性肿瘤微环境（TME）并促进胶质母细胞瘤的演变。
Cell Commun Signal. 2024 Jun 18;22(1):333. doi: 10.1186/s12964-024-01602-0.

本文引用的文献

1
Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols.照射剂量对胶质母细胞瘤患者生存率和生活质量的影响：一项关于RTOG和MDACC方案的前瞻性、2期随机对照研究
Neurooncol Pract. 2020 Jan;7(1):86-93. doi: 10.1093/nop/npz024. Epub 2019 Jul 18.
2
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes.一项新诊断的胶质母细胞瘤患者采用 5 毫米边缘 5 分数次立体定向放射外科手术联合替莫唑胺治疗的 I/II 期临床试验：主要结果。
Neuro Oncol. 2020 Aug 17;22(8):1182-1189. doi: 10.1093/neuonc/noaa019.
3
Progress Toward Long-Term Survivors of Glioblastoma.胶质母细胞瘤的长期生存进展。
Mayo Clin Proc. 2019 Jul;94(7):1278-1286. doi: 10.1016/j.mayocp.2018.11.031. Epub 2019 Jun 20.
4
Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.开发多参数磁共振成像引导放射治疗流程：新诊断胶质母细胞瘤II期临床试验的初步结果
Tomography. 2019 Mar;5(1):118-126. doi: 10.18383/j.tom.2018.00035.
5
Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.放療治療劑量縮減對接受化放療治療膠質母細胞瘤患者淋巴細胞減少的影響。
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):217-225. doi: 10.1016/j.ijrobp.2018.01.069. Epub 2018 Feb 1.
6
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.胶质母细胞瘤的放射治疗：美国放射肿瘤学会循证临床实践指南执行摘要
Pract Radiat Oncol. 2016 Jul-Aug;6(4):217-225. doi: 10.1016/j.prro.2016.03.007. Epub 2016 Mar 31.
7
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?1229例胶质母细胞瘤患者最大安全切除对生存的影响：我们能否比全切除做得更好？
J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.
8
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.贝伐单抗、替莫唑胺与超分割立体定向放射治疗用于新诊断胶质母细胞瘤的II期研究
Clin Cancer Res. 2014 Oct 1;20(19):5023-31. doi: 10.1158/1078-0432.CCR-14-0822. Epub 2014 Aug 8.
9
A randomized trial of bevacizumab for newly diagnosed glioblastoma.贝伐珠单抗治疗新诊断的胶质母细胞瘤的随机试验。
N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573.
10
The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.治疗相关的恶性脑胶质瘤患者淋巴细胞减少症的病因：模拟辐射剂量对循环淋巴细胞的影响可解释临床观察结果，并提出了改变辐射对免疫细胞影响的方法。
Cancer Invest. 2013 Feb;31(2):140-4. doi: 10.3109/07357907.2012.762780.